Preoperative statin treatment is associated with reduced postoperative mortality after isolated cardiac valve surgery in high-risk patients

J Cardiothorac Vasc Anesth. 2010 Dec;24(6):921-6. doi: 10.1053/j.jvca.2010.03.017. Epub 2010 Jul 17.

Abstract

Objective: The aim of the present study was to assess the influence of preoperative statin therapy on postoperative mortality in high-risk patients after isolated valve surgery.

Design: An observational cohort study.

Setting: A 1,200-bed university hospital.

Participants: All consecutive patients undergoing isolated nonemergent valve surgery with cardiopulmonary bypass between November 2005 and December 2007 were included.

Intervention: None.

Measurements and main results: During the period, 772 consecutive patients underwent nonemergent isolated valve surgery. Among them, 430 were high cardiovascular risk (defined by patients with 2 or more cardiovascular risk factors). In the high-risk cardiovascular patients, statin pretreatment was administered in 222 patients (52%). In multivariate analysis, after adjustment with a propensity score analysis, preoperative statin therapy was associated with a significant reduction of postoperative mortality in patients with high risk (odds ratio = 0.41; 95% confidence interval, 0.17-0.97; p = 0.04). Low left ventricular ejection fraction and elevated pulmonary artery pressure also were independently associated with increased postoperative mortality. By contrast, in the low-risk patient group, few patients received preoperative statin therapy (7%).

Conclusions: This study suggests that preoperative statin therapy may have a potential beneficial effect on postoperative mortality after isolated cardiac valve surgery in high-risk cardiovascular patients.

MeSH terms

  • Adult
  • Aged
  • Anesthesia
  • Body Mass Index
  • Cardiac Surgical Procedures / adverse effects
  • Cardiac Surgical Procedures / mortality*
  • Cardiopulmonary Bypass
  • Cardiovascular Diseases / complications
  • Cause of Death
  • Cohort Studies
  • Endpoint Determination
  • Female
  • Heart Valves / surgery*
  • Hemodynamics / physiology
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Male
  • Middle Aged
  • Monitoring, Intraoperative
  • Multivariate Analysis
  • Postoperative Complications / epidemiology
  • Postoperative Complications / mortality*
  • Postoperative Complications / prevention & control*
  • Preoperative Care*
  • Propensity Score
  • Risk
  • Risk Factors

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors